10th Advances Against Aspergillosis and Mucormycosis
2 - 3 February 2022
Virtual Event
10th Advances Against Aspergillosis and Mucormycosis
2 - 3 February 2022
Virtual Event
10th Advances Against Aspergillosis and Mucormycosis
2 - 3 February 2022
Virtual Event
Posters & Abstract Book
You can view the Programme & Abstract Book using the link below:
Posters
The Poster Session Index contains a full list of the posters which were presented at the meeting:
The posters listed in the PDF below were selected as being the best presented at the meeting by the Sage Squads. Congratulations to all involved.
To view a poster, scroll down the list to the appropriate number and click the Poster PDF button.
Poster 001
New modeling approach for chronic pulmonary aspergillosis (CPA) in the context of pulmonary tuberculosis
DW Denning*
Poster 002
Prevalence of pathogenic Aspergillus species in atmosphere during ten years (2011-2021) in Kathmandu, Nepal
U Shrestha Khwakhali*, DW Denning
Poster 003
First case report of aspergillosis in hematological malignancy patients at King Abdulaziz Hospital, Jeddah, Saudi Arabia
A Khateb*, A Barefah, S Bahashwa, O Radwi, E Azhar
Poster 004
First case report of aspergillosis in COVID19 patients in Medina, Saudi Arabia
A Khateb*, F Alof, A Almutairi
Poster 005
Taking a closer look: clinical and histopathological characteristics of culture-positive versus culture-negative pulmonary mucormycosis
A Spallone*, CA Moran, S Wurster, DB Axell-House, DP Kontoyiannis
This abstract has also been selected for Oral Presentation
Poster 006
Prognostic utility of glycemic trends in patients with hematologic malignancy and mucormycosis
A Franklin*, S Wurster, DB Axell-House, Y Jiang, DP Kontoyiannis
Poster 007
An observational study on the epidemiology, risk factors, management and outcomes of COVID-19 associated mucormycosis in Imam Khomeini Hospital complex, Tehran, Iran
S Khodavaisy*, MR Salehi, L Alcazar-Fuoli, SJ Hashemi, F Pakdel, A Tabari, F Ahmadkhani, A Abdollahi, SA Dehghan Manshadi, R Daie Ghazvini, MJ Buitrago, JC Soto-Debran, K Ahmadikia, M Abdorahimi, A Elmimoghaddam, P Afarinesh, RS Kiyaeie
Poster 008
Pulmonary mucormycosis. Findings in high resolution computerized tomography: experiences from a Vietnamese tertiary hospital
NTB Ngoc*, LN Huy, P Michel
Poster 009
The hidden threat of COVID-19: mucormycosis
S Kömür*, B Kurtaran, AS İnal, F Kuşcu, A Candevir, Y Taşova
Poster 010
Challenges faced in managing the rhino-cerebral mucormycosis during COVID-19 pandemic in resource limited settings
GPS Gunaratna*, KMT Bandara, PSMJU Samarakoon, MM Jayasinghe, D Jayasekera, PI Jayasekera, NS Chandrasiri
Chronic rhino-orbito-cerebral mucormycosis: a case report
I Dhib*, A Yaacoub, M Bellakhdhar, N Ben Messoud, R Mooatamri, M Abdelkéfi, H Khochtali, A Fathallah
Poster 012
Occurrences of cryptic Aspergillus species and Talaromyces marneffei in severe chronic pulmonary aspergillosis patients from Indonesia: a case series
AR Rozaliyani*, FS Setianingrum, AA Abdullah, SA Azahra, AEF Fatril, HR Rosianawati, EB Burhan, DH Handayani,
MT Tugiran, RA Adawiyah, RS Syam, RW Wahyuningsih, HW Wibowo, CK Kosmidis, DW Denning
Poster 013
Impact of positive Aspergillus antibody on quality-of-life of patients with smear and/or Genxpert negative pulmonary tuberculosis
AR Rozaliyani*, FS Setianingrum, TD Damayanti, ARA Arifin, FI Isbaniyah, DB Bahtiar, RR Ramdhani, SD Dhunny,
PA Astuti, FN Nandipinto, RA Adawiyah, MT Tugiran, RS Syam, HW Wibowo, CK Kosmidis, DWD Denning
Poster 014
Cerebral mucormycosis: a national study (France, 2005-2020)
CD de La Porte*, CP Provost, AS Serris, AC Coste, MB Bougnoux, RB Herbrecht, VB Bru, FA Ader, FP Persat, EC Canet,
FM Morio, BD Denis, AA Alanio, LL Lelièvre, SC Cassaing, RS Sonneville, LM Millon, OL Lortholary, ON Naggara,
FL Lanternier, French Cerebral Mucormycosis Study Group
Poster 015
Mucormycosis in changed circumstances: unabated scourge of an ongoing Covid 19 pandemic in India
J Chander*
This abstract has also been selected for Oral Presentation
Poster 016
Chronic pulmonary aspergillosis among presumed tuberculosis patients at a tertiary hospital in Ghana
BK Ocansey*, A Adjei, H Gbadamosi, C Kosmidis, J Afriyie-Mensah, JO Opintan, DW Denning
Poster 017
COVID-19 associated mucormycosis from India: a multicentric study on clinical profile, risk factors, cumulative mortality and factors affecting outcome C
M Sahu*, M Shah, MV Rao, VR Kola, HK Boorugu, AR Punjani, RV Kumar, S Kumar, M Manusrut, RK Rathod,
HK Gonuguntla, GK Yedlapati, GR Mallu, YS Reddy, RN KomalKumar, GS Jaishetwar, KR Balasubramoniam, SCR Kumar,
B Nagaraju, PR Sahoo
Poster 018
Bilateral invasive Aspergillus otomycosis in a diabetic patient: a case report
M Smida, A Meherzi, H Chouaieb, M Chatti, M Ben Seif, R Hajlaoui, M Abdelkefi, A Fathallah*
Poster 019
Cutaneous mucormycosis in a kidney transplant patient: a case report
A Azzabi, O Mahfoudh, N Ben Aicha, W Sahtout, A Ayadi, Z Lajmi, M Smida, H Chouaieb, M Chatti, S Ismail, R Boukadida, F Sabri, S Ben Amor, D Zellama, S Hmissa, H Kochtali, A Fathallah*, Y Guedri, A Achour
Poster 020
Chronic pulmonary aspergillosis (CPA) in a patient suffering from granulomatosis with polyangiitis (GPA): a case report
A Knaz, A Omrane, H Chouaieb, M Chatti, R Mrassi, S Ismail, M Ben Seif, W Benzarti, MA Ayed, A Abdelghani, A Hayouni, S Aissa, I Gargouri, A Fathallah*
Poster 021
Epidemiologic spectrum of Aspergillus involved in mycosis in region of Monastir, Tunisia: a 5 year retrospective study
Y Bahri*, S Ben.Belgacem, Y Maatouk, A Ben.Salah, M Mastouri
Poster 022
The epidemiological characteristics of otomycosis in Monastir: a 5 years retrospective study (2016-2020)
Y Bahri*, S Ben.Belgacem, Y Maatouk, A Ben.Salah, M Mastouri
Poster 023
Siderophore-based non-invasive differentiation of Aspergillus fumigatus colonization and invasion in pulmonary aspergillosis
D Luptáková*, RH Patil, R Dobiáš, DA Stevens, T Pluháček, A Palyzová, A Škríba, V Havlíček
Poster 024
Primary cutaneous aspergillosis with secondary pulmonary dissemination
H Jaziri*, I Khammari, W Chenbah, B Achour, A Khelif, A Fathallah
Poster 025
Research on the diagnostic performance of several different galactomannan methodologies for invasive aspergillosis
QQ Zhang*
Poster 026
Clinical performance evaluation of a novel monotest glactomannan detection in the diagnosis of invasive aspergillosis
QQ Zhang*
Poster 027
Access to diagnostics for aspergillosis in Africa
ES Orefuwa, R Penney, DW Denning*
Poster Withdrawn
Poster 028
Siderophore-based monitoring of posaconazole therapy in a rat model of invasive pulmonary aspergillosis
J Houst*, A Skriba, A Palyzova, T Pluhacek, M Petrik, V Havlicek
Poster 029
Invasive necrotic maxillo-nasal aspergillosis in a child with bone marrow aplasia: a case report
Y Bahri, S Ismail, N Ben Sayed, W Chambah, M Chatti, H Chouaieb, N Sassi, Y Ben Youssef, B Sriha, H Regaieg, B Achour, M Mokni, A Khelif, A Fathallah*
Poster 030
Fungal infections in patients with COVID 19. Retrospective study on 65 cases
M Chatti, S Ismail, H Chouaieb, M Ben Seif, R Mrassi, I Khammari, A Fathallah*
Diagnosis of COVID-19 associated pulmonary aspergillosis among mechanically ventilated COVID-19 patients using Galactomannan Lateral Flow Assay and culture
MT Hedayati*, M Ghazanfari, A Arastehfar, L Davoodi, J Yazdani Charati, M Hoenigl, W Pan
This abstract has also been selected for Oral Presentation
Poster 032
Development of a novel qPCR, using mitochondrial genes for the detection of mucormycosis
L Petric*, K Rosam, T van Rens, F Hagen, M Lackner
Poster 033
Detection and identification of mucormycosis agents in native and formalin-fixed paraffin-embedded tissue samples of patients with mycosis using multiplex real time PCR
S Ignatyeva*, T Bogomolova, Y Avdeenko, S Khostelidi, O Shadrivova, Y Borzova, I Zuzgin, J Chudinovskikh, M Motalkina, M Popova, O Uspenskaya, N Klimko, N Vasilyeva
Poster 034
A high incidence of mucormycosis among patients with COVID-19, northeastern Iran
SS Mojtahedi, H Zarrinfar*, MJ Najafzadeh, M Bakhshaee
Poster 035
Molecular identification of Aspergillus species in bronchoalveolar lavage specimens of susceptible children with respiratory disorders
E Kashefi, SJ Seyedi, H Zarrinfar*, AM Fata, H Mehrad-Majd, MJ Najafzadeh
Poster 036
Aspergillus rhinosinusitis among patients with COVID-19, northeastern Iran
SS Mojtahedi*, H Zarrinfar, MJ Najafzadeh, M Bakhshaee
Poster 037
Cross-reactivity of an Aspergillus spp. quantitative PCR based on an 18S rRNA probe; experience of the Mycology Reference Centre Manchester
E Bradshaw, P Chandorkar, E Hopwood, E Kington, MD Richardson, R Rautemaa-Richardson, L Novak Frazer*
Poster 038
Aspergillus fumigatus pan-genome analysis identifies genetic variants associated with human infection
AE Barber*, T Sae-Ong, K Kang, B Seelbinder, J Li, G Walther, G Panagiotou, O Kurzai
This abstract has also been selected for Oral Presentation
Poster 039
Virus infection impairs fungal response to stress: effect of salt
DA Stevens*, I Kotta-Loizou, M Martinez, RHA Coutts, G Sass
Poster 040
Germination behaviour and fate of Rhizopus stolonifer in autoclaved and agricultural soil collected from Tea Ecosystem
S Debnath*
Poster 041
The Aspergillus fumigatus morphogenesis-related kinase, CotA, orchestrates hyphal growth in response to carbon source quality
A Martin-Vicente*, AV Nywening, X Guruceaga, H Thorn, J Xie, W Ge, JR Fortwendel
Poster 042
Mycotoxin secretion by Aspergillus fumigatus as a response to mycovirus infection
RH Patil*, I Kotta-Loizou, A Palyzová, T Pluháček, R Coutts, DA Stevens, V Havlíček
Poster 043
COVID-19 associated pulmonary aspergillosis isolates exhibit high genomic heterogeneity but are more similar to each other in their response to infection-relevant stresses
ME Mead*, PA de Castro, JL Steenwyk, M Hoenigl, J Prattes, R Rautemaa-Richardson, CB Moore, C Lass-Flörl,
JP Gangneux, H Guegan, N Van Rhinj, A Rokas, GH Goldman, S Gago
Poster 044
Mycovirus affects biological properties in Aspergillus fumigatus
A Ikeda, Y Chiba, SI Urayama, D Hagiwara*
Poster 045
The transcription factor ZfpA is a global regulator essential for proper hyphal development in Aspergillus fumigatus
DG Calise*, JW Bok, NP Keller
Poster 046
Characterization of Mucor circinelloides sterol-14-alpha-demethylases expressed in Saccharomyces cerevisiae
K Rosam*, M Keniya, L Zenz, C Müller, P Schuchter, L Bachstein, BC Monk, M Lackner
Poster 047
Aspergillus fumigatus Septation Initiation Network (SIN) kinases contribute to fungal pathogenesis, cell wall construction, and rRNA metabolism
X Guruceaga*, A Martin-Vicente, ACO Souza, AV Nywening, H Thorn, J Xie, W Ge, BM Peters, JR Fortwendel
Poster 048
GAG, a polysaccharide cytotoxin?
CA Zacharias*, FN Gravelat, FA Le Mauff, H Liu, SG Filler, DC Sheppard
Poster 049
Relative abundance and geospatial stratification of airborne Mucoromycota is a poor predictor of mucormycosis
SK Kutmutia*, SC Chotirmal, MF Fischer, SCS Schuster
Poster 050
Characterizing genomic and phenotypic traits of the human pathogen Aspergillus flavus and its non-pathogenic close relatives
EA Hatmaker*, M Rangel Grimaldo, RW Bastos, H Pourhadi, S Knowles, K Fuller, G Goldman, N Oberlies, A Rokas
Poster 051
Identification of novel transcription factors involved in Aspergillus fumigatus adherence
S Liu, Y Abu Yousef, DC Sheppard, S Zhang, F Le Mauff*
Poster 052
A mutation in the class III histidine-kinase Bos1 is responsible for Aspergillus fumigatus dicarboximide resistance
J Lucio*, I Gonzalez-Jimenez, E Mellado
Poster 053
The Aspergillus fumigatus DNA mismatch repair system and its relation with azole resistance
I Gonzalez-Jimenez*, J Lucio, A Roldan, L Alcazar-Fuoli, E Mellado
Poster 054
Potentially voriconazole resistant environmental Aspergillus strains in the Basque Country
S Cendon-Sanchez*, U Perez-Cuesta, E Pelegri-Martinez, X Guruceaga, G Gonzalez-Otero, I Buldain, A Antoran,
A Ramirez-Garcia, A Abad-Diaz-de-Cerio, A Rementeria
Poster 055
Isolation of Aspergillus fumigatus with Y121H or Y121F single cyp51A mutations after isavuconazole or voriconazole treatment
MJ Iglesias-Cabezas*, J Lucio, I González-Jiménez, N Román, M Estopiña-Antolí, J Ayats, MJ Buitrago, E Mellado
Poster 056
The Aspergillus fumigatus spindle assembly checkpoint components, sldA and sldB, play roles in maintenance of triazole susceptibility
AV Nywening*, AM Vicente, W Ge, JR Fortwendel
Poster 057
Commercial tea samples: a natural health ally or an Aspergillus infusion?
B Gomes*, M Dias, R Cervantes, L Aranha Caetano, C Viegas
Poster 058
Are we neglecting the importance of azole resistance screening in indoor air quality assessments?
C Viegas*, B Almeida, B Gomes, M Dias, R Cervantes, L Aranha Ceatano
Poster 059
Aspergillus sp. distribution on waste collection trucks
M Dias*, P Pena, R Cervantes, B Gomes, L Aranha-Caetano, C Viegas
Poster 060
Azole-resistance of Mucorales order in three occupational environments and potential health risks for workers
LA Caetano*, B Gomes, M Dias, P Pena, R Cervantes, C Viegas
Antifungal susceptibility testing of clinical Aspergillus isolates from Saint Petersburg, Russia
NV Vasilyeva*, IV Vybornova, SV Kovyrshin, TS Bogomolova, IA Bosak, GA Chilina, OV Shadrivova
Poster 062
Stradam, a novel natural antifungal from the Canadian Arctic microbiome
EJ Côté*, A Classen, E Marcolefas, J Ronholm, DC Sheppard, L Whyte, F Le Mauff
This abstract has also been selected for Oral Presentation
Poster 063
Antifungal activity of nanoparticles of zinc, copper, cerium oxide, silver, gold and selenium against clinical isolates of Aspergillus
SH Moghadam*, B Azari, H Zarrinfar, M Darroudi
Poster 064
Fungal pathogenesis and treatment through the lens of RNA regulation
AA Kelani, A Bruch, C Visser, AA Brakhage, MG Blango*
Poster 065
Exploring a novel genomic safe-haven site in the human pathogenic mould Aspergillus fumigatus
TF Furukawa*, NvR van Rhijn, JR Rhodes, RFG Fortune-Grant, EB Bignell, MF Fisher, MB Bromley
Poster 066
Study of the Afu6g07200 gene of Aspergillus fumigatus: first granulin activity in fungi?
U Perez-Cuesta*, X Guruceaga, S Cendon-Sanchez, E Pelegri-Martinez, A Prieto-Fiel, I Buldain, A Antoran,
A Ramirez-Garcia, A Abad-Diaz-de-Cerio, A Rementeria
Poster 067
Aspergillus fumigatus persistence in cystic fibrosis: adaptation to hypoxia and osmotic stress through in-host HOG pathway mutation
BS Ross*, LA Lofgren, A Ashare, JE Stajich, RA Cramer
Poster 068
In Aspergillus fumigatus, the mutation in insulin-induced protein (Insig) gene is a novel factor that contributes additively to azole resistance in collaboration with the Cyp51A mutation
T Arai*, H Takahashi, Y Kusuya, H Majima, A Watanabe, K Kamei
Poster 069
Codon optimization and promoter selection facilitates use of Mucor circinelloides for reporter assays to monitor infection and antifungal efficacy
U Binder*, MI Navarro-Mendoza, FE Nicolas, C Kandelbauer, R Pföstl, I Bauer, C Lass-Flörl, V Garre
Poster 070
Characterisation of MAIT cells in the antifungal immune response in a microfluidic “invasive aspergillosis-on-chip” disease model
S Grau, S Hartung, Z Cseresnyés, M Hoang, K Rennert, AS Mosig, MT Figge, M von Lilienfeld-Toal, S Jahreis*
This abstract has also been selected for Oral Presentation
Poster 071
Analysis of chronic biological responses between host and fungus ball using a novel aspergilloma mouse model
R Hamashima*, M Tashiro, Y Nakano, N Ashizawa, K Takeda, N Iwanaga, K Nishi, A Fujita, T Takazono, T Tanaka,
K Yamamoto, H Liu, Y Komohara, A Furumoto, K Yanagihara, H Mukae, SG Filler, K Takayama, K Izumikawa
Poster 072
Immunological relevance of the mammalian receptor G2A in the host response to Aspergillus fumigatus pulmonary infection
BN Steffan*, DG Calise, NP Keller
This abstract has also been selected for Oral Presentation
Poster 073
Deciphering the mechanisms by which fungal spores drive lung dendritic cell subsets to elicit allergic inflammation
J Furlong-Silva*, G Vere, BM Invergo, AR Jeffries, G Brown, E Bignell, PC Cook
Poster Withdrawn
Poster 074
5-Hydroxytryptamine receptor 1A (5-HT1A) is required for Drosophila melanogaster host defense against Aspergillus fumigatus infection and the mycotoxins it secrets
R Yan, AC Chen*, D Ferrandon
Poster 075
Aspergillus melanin modulates neutrophil influx into airways through blocking secretion of pro-inflammatory cytokines by human airway epithelial cells
JL Reedy*, AJ Crossen, JM Vyas
Poster 076
The role of the complement system in a murine model of disseminated mucormycosis
V Harpf*, L Riepl, G Rambach, V Fleischer, C Lass-Flörl, R Würzner, C Speth
Poster 077
Blockade of the PD-1/PD-L1 immune checkpoint pathway enhances host defense against Mucorales and improves outcomes in a murine model of invasive pulmonary mucormycosis
S Wurster*, ND Albert, U Bharadwaj, MM Kasembeli, DP Kontoyiannis
Poster 078
Establishment of a pathophysiologically relevant post-influenza aspergillosis model in corticosteroid-immunosuppressed mice
S Wurster*, JP García, ND Albert, S Evans, DP Kontoyiannis
Poster 079
SiRNA-mediated knockdown of CFTR in A549 cells is associated with increased expression of IL-6 and defective killing in response to Aspergillus fumigatus conidia
K Earle*, M Bromley, P Bowyer, S Gago
Poster 080
Mutual inhibition of antifungal and antiviral airway epithelial responses during fungal–viral coinfection
P Dancer, A Pickard, W Potocka, K Kadler, M Bertuzzi, S Gago*
This abstract has also been selected for Oral Presentation
Poster 081
Aspergillus fumigatus hyphal branching mutant shows enhanced susceptibility to host defenses and caspofungin in vivo
TJ Schoen*, DG Calise, M Niu, JW Bok, A Huttenlocher, NP Keller
Poster 082
Differential inflammatory response of bronchial epithelial cells to Aspergillus fumigatus – Stenotrophomonas maltophilia isolates derived from CF individuals
L Roisin, N Hammoudi, L Monpierre, V Balloy, M Blatzer, I Valsecchi, F Botterel*
Poster 083
Isoeugenol modulates expression pattern of transcriptional regulators MedA, SomA and conidial hydrophobin gene RodA in Aspergillus fumigatus
L Gupta*, P Vijayaraghavan
Poster 084
Evaluation of antifungal drugs by an invasive aspergillosis-on-chip model
S Hartung*, TNM Hoang*, Z Cseresnyes*, N Schuck, K Rennert, F Klos, AS Mosig, MT Figge, M von Lilienfeld-Toal
Poster 085
Molecular docking analysis of plant-derived small molecules against virulence factors-spore coat protein (CotH3) and high affinity iron permease protein (FTR1) of Rhizopus oryzae
H Kamboj*, M Vijay, L Gupta, P Vijayaraghavan
Poster 086
Microhemorrhage-associated tissue iron causes macrophage lysosomal leakage and loss, which increases the risk for invasive aspergillosis in a cystic fibrosis mouse model of airway transplantation
EI Matthaiou*, W Chiu, C Conrad, J Hsu
Poster 087
Infection metallomics as a tool for functional studies in Aspergillus fumigatus
D Luptakova, RH Patil, V Havlicek*
Poster 088
The role of cytochrome c in leukocyte induced Aspergillus fumigatus cell death
M James*, KW Liu, E Vesley, T Hohl, RA Cramer
Poster 089
Targeted delivery of antifungal liposomes to Rhizopus delemar
QJ Choudhury*, S Ambati, X Lin, ZA Lewis, RB Meagher
Poster 090
Treatment of aspergillosis, candidiasis, and cryptococcosis with DectiSomes
ZA Lewis, RB Meagher*, S Ambati, X Lin
Poster 091
Anti-PD1 plus interferon-γ associated with antifungal therapy in the treatment of refractory Covid-associated pulmonary aspergillosis and cerebral mucormycosis
AS Serris*, FU Uhel, GMB Martin-Blondel, OL Lambotte, MEB Bougnoux, EL Litvinova, AO Ouedrani, CR Rouzaud,
VB Bedarida, JHR Raphalen, FL Lanternier
Poster 092
Effect of iron on Aspergillus proteases: insight into possible therapeutic target for allergic bronchopulmonary aspergillosis
PC Chatterjee*, WC Chiu, EBB Burgener, PLB Bollyky, JH Hsu
This abstract has also been selected for Oral Presentation
Poster 093
Targeting Aspergillus fumigatus hypoxia response pathways to potentiate contemporary antifungal therapies
C Gutierrez Perez*, S Dhingra, SM Kwansy, TJ Opperman, RA Cramer
